POCI Quote, Financials, Valuation and Earnings

Daxor Corp. has a net margin of -24.5% compared to Precision Optics Corp., Inc.'s net margin of --. Precision Optics Corp., Inc.'s return on equity of -54.55% beat Daxor Corp.'s return on equity of 1.57%.

Precision Optics Corp., Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Daxor Corp. has an analysts' consensus of $22.00 which suggests that it could grow by 71.21%. Given that Daxor Corp. has higher upside potential than Precision Optics Corp., Inc., analysts believe Daxor Corp. is more attractive than Precision Optics Corp., Inc..

Precision Optics Corp., Inc. has a beta of 0.296, which suggesting that the stock is 70.404% less volatile than S&P 500. In comparison Daxor Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100.015%.

Precision Optics Corp., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Daxor Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision Optics Corp., Inc. pays -- of its earnings as a dividend. Daxor Corp. pays out -- of its earnings as a dividend.

Precision Optics Corp., Inc. quarterly revenues are $6.7M, which are larger than Daxor Corp. quarterly revenues of --. Precision Optics Corp., Inc.'s net income of -$1.6M is higher than Daxor Corp.'s net income of --. Notably, Precision Optics Corp., Inc.'s price-to-earnings ratio is -- while Daxor Corp.'s PE ratio is 35.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision Optics Corp., Inc. is 1.40x versus 59.58x for Daxor Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Phibro Animal Health Corp. has a net margin of -24.5% compared to Precision Optics Corp., Inc.'s net margin of 7.29%. Precision Optics Corp., Inc.'s return on equity of -54.55% beat Phibro Animal Health Corp.'s return on equity of 24.77%.

Precision Optics Corp., Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 5.47%. Given that Phibro Animal Health Corp. has higher upside potential than Precision Optics Corp., Inc., analysts believe Phibro Animal Health Corp. is more attractive than Precision Optics Corp., Inc..

Precision Optics Corp., Inc. has a beta of 0.296, which suggesting that the stock is 70.404% less volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.

Precision Optics Corp., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.18% to investors and pays a quarterly dividend of $0.12 per share. Precision Optics Corp., Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Precision Optics Corp., Inc. quarterly revenues are $6.7M, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. Precision Optics Corp., Inc.'s net income of -$1.6M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Precision Optics Corp., Inc.'s price-to-earnings ratio is -- while Phibro Animal Health Corp.'s PE ratio is 24.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision Optics Corp., Inc. is 1.40x versus 1.19x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Sanara MedTech, Inc. has a net margin of -24.5% compared to Precision Optics Corp., Inc.'s net margin of 3.17%. Precision Optics Corp., Inc.'s return on equity of -54.55% beat Sanara MedTech, Inc.'s return on equity of -20.48%.

Precision Optics Corp., Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sanara MedTech, Inc. has an analysts' consensus of $41.00 which suggests that it could grow by 88.07%. Given that Sanara MedTech, Inc. has higher upside potential than Precision Optics Corp., Inc., analysts believe Sanara MedTech, Inc. is more attractive than Precision Optics Corp., Inc..

Precision Optics Corp., Inc. has a beta of 0.296, which suggesting that the stock is 70.404% less volatile than S&P 500. In comparison Sanara MedTech, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.199%.

Precision Optics Corp., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sanara MedTech, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision Optics Corp., Inc. pays -- of its earnings as a dividend. Sanara MedTech, Inc. pays out -- of its earnings as a dividend.

Precision Optics Corp., Inc. quarterly revenues are $6.7M, which are smaller than Sanara MedTech, Inc. quarterly revenues of $26.3M. Precision Optics Corp., Inc.'s net income of -$1.6M is lower than Sanara MedTech, Inc.'s net income of $834.5K. Notably, Precision Optics Corp., Inc.'s price-to-earnings ratio is -- while Sanara MedTech, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision Optics Corp., Inc. is 1.40x versus 1.84x for Sanara MedTech, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Warby Parker, Inc. has a net margin of -24.5% compared to Precision Optics Corp., Inc.'s net margin of 2.65%. Precision Optics Corp., Inc.'s return on equity of -54.55% beat Warby Parker, Inc.'s return on equity of 0.2%.

Precision Optics Corp., Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Warby Parker, Inc. has an analysts' consensus of $22.45 which suggests that it could grow by 20.34%. Given that Warby Parker, Inc. has higher upside potential than Precision Optics Corp., Inc., analysts believe Warby Parker, Inc. is more attractive than Precision Optics Corp., Inc..

Precision Optics Corp., Inc. has a beta of 0.296, which suggesting that the stock is 70.404% less volatile than S&P 500. In comparison Warby Parker, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Precision Optics Corp., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Warby Parker, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision Optics Corp., Inc. pays -- of its earnings as a dividend. Warby Parker, Inc. pays out -- of its earnings as a dividend.

Precision Optics Corp., Inc. quarterly revenues are $6.7M, which are smaller than Warby Parker, Inc. quarterly revenues of $221.7M. Precision Optics Corp., Inc.'s net income of -$1.6M is lower than Warby Parker, Inc.'s net income of $5.9M. Notably, Precision Optics Corp., Inc.'s price-to-earnings ratio is -- while Warby Parker, Inc.'s PE ratio is 4,847.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision Optics Corp., Inc. is 1.40x versus 2.67x for Warby Parker, Inc.. Usually stocks with elevated PS ratios are considered overvalued.